Home LiteratureArticle Details
PMID: 12097147 Published · epublish English Journal Article

A novel link between the proteasome pathway and the signal transduction pathway of the bone morphogenetic proteins (BMPs).

BMC cell biology ·Vol. 3 ·2002-06-21 ·Pages 15

Lin Y, Martin J, Gruendler C, Farley J, Meng X, Li BY, Lechleider R, Huff C, Kim RH, Grasser WA, Paralkar V, Wang T

Abstract

The intracellular signaling events of the bone morphogenetic proteins (BMPs) involve the R-Smad family members Smad1, Smad5, Smad8 and the Co-Smad, Smad4. Smads are currently considered to be DNA-binding transcriptional modulators and shown to recruit the master transcriptional co-activator CBP/p300 for transcriptional activation. SNIP1 is a recently discovered novel repressor of CBP/p300. Currently, the detailed molecular mechanisms that allow R-Smads and Co-Smad to co-operatively modulate transcription events are not fully understood. Here we report a novel physical and functional link between Smad1 and the 26S proteasome that contributes to Smad1- and Smad4-mediated transcriptional regulation. Smad1 forms a complex with a proteasome beta subunit HsN3 and the ornithine decarboxylase antizyme (Az). The interaction is enhanced upon BMP type I receptor activation and occur prior to the incorporation of HsN3 into the mature 20S proteasome. Furthermore, BMPs trigger the translocation of Smad1, HsN3 and Az into the nucleus, where the novel CBP/p300 repressor protein SNIP1 is further recruited to Smad1/HsN3/Az complex and degraded in a Smad1-, Smad4- and Az-dependent fashion. The degradation of the CBP/p300 repressor SNIP1 is likely an essential step for Smad1-, Smad4-mediated transcriptional activation, since increased SNIP1 expression inhibits BMP-induced gene responses. Our studies thus add two additional important functional partners of Smad1 into the signaling web of BMPs and also suggest a novel mechanism for Smad1 and Smad4 to co-modulate transcription via regulating proteasomal degradation of CBP/p300 repressor SNIP1.

MeSH Terms
Animals Blotting, Western Bone Morphogenetic Protein 2 Bone Morphogenetic Protein Receptors, Type I Bone Morphogenetic Proteins/genetics,metabolism,pharmacology COS Cells Carrier Proteins/genetics,metabolism Cell Line Cysteine Endopeptidases/genetics,metabolism DNA-Binding Proteins/genetics,metabolism Gene Expression Regulation/drug effects Humans Intracellular Signaling Peptides and Proteins Multienzyme Complexes/metabolism Mutation Precipitin Tests Proteasome Endopeptidase Complex Protein Binding/drug effects Protein Precursors/genetics,metabolism Protein Serine-Threonine Kinases/genetics,metabolism RNA-Binding Proteins Receptors, Growth Factor/genetics,metabolism Signal Transduction Smad Proteins Smad1 Protein Trans-Activators/genetics,metabolism Transcription, Genetic Transforming Growth Factor beta Tumor Cells, Cultured Two-Hybrid System Techniques
Chemicals
BMP2 protein, human Bone Morphogenetic Protein 2 Bone Morphogenetic Proteins Carrier Proteins DNA-Binding Proteins Intracellular Signaling Peptides and Proteins Multienzyme Complexes Protein Precursors RNA-Binding Proteins Receptors, Growth Factor SMAD1 protein, human SNIP1 protein, human Smad Proteins Smad1 Protein Trans-Activators Transforming Growth Factor beta Protein Serine-Threonine Kinases Bone Morphogenetic Protein Receptors, Type I Cysteine Endopeptidases PSMB4 protein, human Proteasome Endopeptidase Complex
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Lin Yin
Virginia Mason Research Center, 1201 Ninth Ave, Seattle WA 98101, USA. yinlinn@yahoo.com
Martin Jennifer
Gruendler Cornelia
Farley Jennifer
Meng Xianwang
Li Bi-Yu
Lechleider Robert
Huff Carla
Kim Richard H
Grasser William A
Paralkar Vishwas
Wang Tongwen
References (54)
54 references, click to expand
  1. Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein.
    Science. 1999 Oct 22;286(5440):771-4 PMID: 10531062
  2. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation.
    Nature. 1999 Aug 12;400(6745):687-93 PMID: 10458166
  3. Ubiquitin-dependent degradation of TGF-beta-activated smad2.
    Nat Cell Biol. 1999 Dec;1(8):472-8 PMID: 10587642
  4. The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain.
    J Biol Chem. 2000 Jan 21;275(3):2115-22 PMID: 10636916
  5. Regulation of Smad activity.
    Cell. 2000 Jan 21;100(2):189-92 PMID: 10660041
  6. Smads as transcriptional co-modulators.
    Curr Opin Cell Biol. 2000 Apr;12(2):235-43 PMID: 10712925
  7. Controlling TGF-beta signaling.
    Genes Dev. 2000 Mar 15;14(6):627-44 PMID: 10733523
  8. A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction.
    Genes Dev. 2000 Jul 1;14(13):1605-16 PMID: 10887155
  9. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling.
    J Biol Chem. 2000 Nov 24;275(47):36818-22 PMID: 11016919
  10. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase.
    Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):974-9 PMID: 11158580
  11. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation.
    Mol Cell. 2000 Dec;6(6):1365-75 PMID: 11163210
  12. 20S proteasome biogenesis.
    Biochimie. 2001 Mar-Apr;83(3-4):289-93 PMID: 11295488
  13. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation.
    J Biol Chem. 2001 Apr 20;276(16):12477-80 PMID: 11278251
  14. Sorting nexin 6, a novel SNX, interacts with the transforming growth factor-beta family of receptor serine-threonine kinases.
    J Biol Chem. 2001 Jun 1;276(22):19332-9 PMID: 11279102
  15. Dendritic growth induced by BMP-7 requires Smad1 and proteasome activity.
    J Neurobiol. 2001 Aug;48(2):120-30 PMID: 11438941
  16. Proteasomal degradation of Smad1 induced by bone morphogenetic proteins.
    J Biol Chem. 2001 Dec 7;276(49):46533-43 PMID: 11571290
  17. cDNA sequence coding for a translationally controlled human tumor protein.
    Nucleic Acids Res. 1989 Oct 25;17(20):8367 PMID: 2813067
  18. Cloning and characterization of a human c-myc promoter-binding protein.
    Mol Cell Biol. 1991 Apr;11(4):2154-61 PMID: 2005901
  19. Regulation of cartilage and bone differentiation by bone morphogenetic proteins.
    Curr Opin Cell Biol. 1992 Oct;4(5):850-5 PMID: 1419064
  20. A human cDNA corresponding to a gene overexpressed during cell proliferation encodes a product sharing homology with amoebic and bacterial proteins.
    J Biol Chem. 1993 May 25;268(15):11050-6 PMID: 8496166
  21. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms.
    Genes Dev. 1994 Jan;8(2):133-46 PMID: 8299934
  22. 20 S proteasomes are assembled via distinct precursor complexes. Processing of LMP2 and LMP7 proproteins takes place in 13-16 S preproteasome complexes.
    J Mol Biol. 1994 Mar 4;236(4):975-81 PMID: 8120905
  23. The transforming growth factor beta family and induction of the vertebrate mesoderm: bone morphogenetic proteins are ventral inducers.
    Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10243-6 PMID: 7937933
  24. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.
    Cell. 1994 Oct 21;79(2):following 388 PMID: 7954804
  25. The human proteasome subunit HsN3 is located in the inner rings of the complex dimer.
    J Mol Biol. 1995 Apr 28;248(2):264-72 PMID: 7537829
  26. Processing of N3, a mammalian proteasome beta-type subunit.
    Biochem J. 1996 May 1;315 ( Pt 3):733-8 PMID: 8645151
  27. MADR1, a MAD-related protein that functions in BMP2 signaling pathways.
    Cell. 1996 May 17;85(4):489-500 PMID: 8653785
  28. A human Mad protein acting as a BMP-regulated transcriptional activator.
    Nature. 1996 Jun 13;381(6583):620-3 PMID: 8637600
  29. Effects on NF-kappa B1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome.
    Nature. 1996 May 23;381(6580):328-31 PMID: 8692272
  30. Bone morphogenetic proteins: multifunctional regulators of vertebrate development.
    Genes Dev. 1996 Jul 1;10(13):1580-94 PMID: 8682290
  31. Ornithine decarboxylase antizyme: a novel type of regulatory protein.
    Trends Biochem Sci. 1996 Jan;21(1):27-30 PMID: 8848835
  32. Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly.
    Cell. 1996 Sep 20;86(6):961-72 PMID: 8808631
  33. Structure and functions of the 20S and 26S proteasomes.
    Annu Rev Biochem. 1996;65:801-47 PMID: 8811196
  34. Assignment of the human antizyme gene (OAZ) to chromosome 19p13.3 by fluorescence in situ hybridization.
    Genomics. 1996 Nov 15;38(1):102-4 PMID: 8954789
  35. Structure of 20S proteasome from yeast at 2.4 A resolution.
    Nature. 1997 Apr 3;386(6624):463-71 PMID: 9087403
  36. Maturation of mammalian 20 S proteasome: purification and characterization of 13 S and 16 S proteasome precursor complexes.
    J Mol Biol. 1997 Apr 25;268(1):95-106 PMID: 9149144
  37. Cloning and characterization of mouse Lmp3 cDNA, encoding a proteasome beta subunit.
    Gene. 1997 May 6;190(2):251-6 PMID: 9197541
  38. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling.
    Cell. 1997 Jun 27;89(7):1165-73 PMID: 9215638
  39. Structure and structure formation of the 20S proteasome.
    Mol Biol Rep. 1997 Mar;24(1-2):103-12 PMID: 9228290
  40. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic.
    Nature. 1997 Jul 17;388(6639):304-8 PMID: 9230443
  41. Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor beta subunits.
    EMBO J. 1997 Sep 1;16(17):5363-75 PMID: 9311996
  42. Targeting of substrates to the 26S proteasome.
    FASEB J. 1997 Nov;11(13):1055-66 PMID: 9367341
  43. Understanding gene and allele function with two-hybrid methods.
    Annu Rev Genet. 1997;31:663-704 PMID: 9442911
  44. Ump1p is required for proper maturation of the 20S proteasome and becomes its substrate upon completion of the assembly.
    Cell. 1998 Feb 20;92(4):489-99 PMID: 9491890
  45. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors.
    EMBO J. 1998 Jul 15;17(14):4056-65 PMID: 9670020
  46. Signal transduction by bone morphogenetic proteins.
    Cytokine Growth Factor Rev. 1998 Mar;9(1):49-61 PMID: 9720756
  47. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.
    J Biol Chem. 1998 Oct 2;273(40):25628-36 PMID: 9748228
  48. TGF-beta signal transduction.
    Annu Rev Biochem. 1998;67:753-91 PMID: 9759503
  49. The proteasome: a protein-destroying machine.
    Genes Cells. 1998 Aug;3(8):499-510 PMID: 9797452
  50. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300.
    Science. 1999 Apr 16;284(5413):479-82 PMID: 10205054
  51. Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling.
    J Biol Chem. 1999 May 7;274(19):13711-7 PMID: 10224145
  52. Regulation of Smad signalling by protein associations and signalling crosstalk.
    Trends Cell Biol. 1999 Jul;9(7):274-9 PMID: 10370243
  53. SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes.
    J Biol Chem. 1999 Jul 16;274(29):20489-98 PMID: 10400677
  54. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling.
    Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12442-7 PMID: 10535941
Article Info
Journal
BMC cell biology
Abbr.
BMC Cell Biol
ISSN
1471-2121
Published
2002-06-21
Epub
2002-00-21
Pages
15
Language
English
Region
England
NLM ID
100966972
PMCID
PMC117437
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com